Microgestin 1.5/30 Kit
Product Images NDC 51862-872

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Microgestin 1.5/30 (NDC 51862-872). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

FDA Label Image

2 (Image 02)

2 (Image 02)
This is a table showing the lowest and typical rates of failure during the first year of continuous use of birth control methods. The percentage of women experiencing unintended pregnancy in the first year of continuous use is provided for each method. The table includes various methods such as oral contraceptives, diaphragm, spermicidal creams, injections, sterilization, etc. The text also includes a note on what the "lowest expected" and "typical" failure rates mean.*
FDA Label Image

3 (Image 03)

3 (Image 03)
Cigarette smoking and oral contraceptive use can lead to serious cardiovascular side effects. The risk is higher for older women and those who smoke heavily (15 or more cigarettes per day). For women over 35, the risk is substantial. It is strongly recommended that women using oral contraceptives should not smoke.*
FDA Label Image

4 (Image 04)

FDA Label Image

5 (Image 05)

5 (Image 05)
This table provides data on the annual number of birth-related or method-related deaths associated with control of fertility per 100,000 nonsterile women by fertility control method according to age. The table presents the results for various methods of control and outcomes for women aged between 15 to 44 years old. The methods include oral contraceptives for smokers and non-smokers, intrauterine devices (IUDs), condoms, diaphragms/spermicides, and periodic abstinence. The table provides important information on the risks associated with different methods of birth control.*
FDA Label Image

6 (Image 06)

6 (Image 06)
Cigarette smoking can lead to severe cardiovascular complications when combined with taking oral contraceptives. The danger enhances with age and heavy smoking habits, which includes smoking 15 or more cigarettes in a day, and can be significant in women who are over 35 years old. It is highly recommended that women who use birth control pills should avoid smoking.*
FDA Label Image

7 (Image 07)

7 (Image 07)
This text provides instructions for starting birth control pills on the first day of the menstrual cycle. It includes information on where to place the day label sticker depending on the start of the period and how to take the pills consistently from left to right every week.*
FDA Label Image

8 (Image 08)

8 (Image 08)
Cigarette smoking and oral contraceptive use can lead to serious cardiovascular side effects, and the risk increases with age and heavy smoking (15 or more cigarettes per day). This risk is particularly high for women over 35, and users of oral contraceptives are strongly advised not to smoke.*
FDA Label Image

9 (Image 09)

9 (Image 09)
The text provides a table with the annual number of birth-related or method-related deaths per 100,000 nonsterile women by fertility control method and age group. The table lists several methods such as no fertility control, oral contraceptives, TUD, condom, diaphragm/spermicide, and periodic abstinence. The outcome for each method is presented for age groups 15-19, 20-24, 25-29, 30-34, 35-39, and 40-44. Deaths are either birth-related or method-related, and the number of deaths per method is provided accordingly.*
FDA Label Image

10 (Image 10)

10 (Image 10)
This appears to be instructions for birth control pills. It provides guidance on how to start taking the pills depending on the starting day of the menstrual cycle, and how to take the pills each week.*
FDA Label Image

11 (Image 11)

FDA Label Image

12 (Image 12)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.